cycloserine 250 mg

INDICATIONS AND USAGE Seromycin ® is indicated in the treatment of active pulmonary and extrapulmonary tuberculosis (including renal disease) when the causative organisms are susceptible to this drug and when treatment with the primary medications (streptomycin, isoniazid, rifampin, and ethambutol) has proved inadequate. Like all antituberculosis drugs, Seromycin ® should be administered in conjunction with other effective chemotherapy and not as the sole therapeutic agent. Seromycin ® may be effective in the treatment of acute urinary tract infections caused by susceptible strains of gram- positive and gram-negative bacteria. Use of Seromycin ® in these infections should be considered only when more conventional therapy has failed and when the organism has been demonstrated to be susceptible to the drug.

Parsolex Gmp Center, Inc.

FDA Reported Adverse Reactions
`[1] nausea` `[2] off label use` `[3] drug ineffective` `[4] fatigue` `[5] diarrhoea` `[6] vomiting` `[7] dyspnoea` `[8] pyrexia` `[9] headache` `[10] pain`

2 years ago

CAPSULE RED PGC F04

HOW SUPPLIED Seromycin ® is available as a 250 mg capsule with an opaque red cap and opaque gray body imprinted with “PGC” and “F04” in edible black ink on both the cap and the body. Aluminum blisters (a pack of 3 cards each with 10 capsules). NDC 13845-1200-2. Store at controlled room temperature, 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].

More pills like CAPSULE PGC F04

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site

cycloserine 250 mg

FDA Reported Adverse Reactions [1] nausea [2] off label use [3] drug ineffective [4] fatigue [5] diarrhoea [6] vomiting [7] dyspnoea [8] pyrexia [9] headache [10] pain

CAPSULE RED PGC F04

More pills like CAPSULE PGC F04

FDA Reported Adverse Reactions
`[1] nausea` `[2] off label use` `[3] drug ineffective` `[4] fatigue` `[5] diarrhoea` `[6] vomiting` `[7] dyspnoea` `[8] pyrexia` `[9] headache` `[10] pain`